AI In Pharma Global Market Opportunities And Strategies To 2032

AI In Pharma Market 2023 – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research And Development, Epidemic Prediction), And By Region, Opportunities And Strategies – Global Forecast To 2032

Starting Price : $4000.00 | Pages : 259 | Published : March 2024 | | Format : pdf

Purchase Options
Request Sample
Request For Discount

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

AI In Pharma Market Definition

The artificial intelligence (AI) in pharma market consists of sales, by entities (organizations, sole proprietors and partnerships), of AI software products in pharma that use an automated algorithm to perform tasks that traditionally rely on human intelligence. It can be useful in handling data and presenting results that encourage better decision-making and save human efforts, cost and time.

AI is concerned with the simulation of human intelligence in machines that are programmed to think like humans and simulate their actions.  AI in pharma refers to the system of interconnected and automated technologies in the pharmaceutical and biotechnology industries that can function autonomously with little or no human intervention.  It can help pharmaceutical companies improve clinical trials, enable predictive power in the R&D (research and development) process and elevate pharma manufacturing.

AI In Pharma Market Size

The global AI in pharma market reached a value of nearly $1,477.78 million in 2022, having grown at a compound annual growth rate (CAGR) of 35.8% since 2017. The market is expected to grow from $1,477.78 million in 2022 to $6,291.91 million in 2027 at a rate of 33.6%. The market is then expected to grow at a CAGR of 18.9% from 2027 and reach $14,958.94 million in 2032.        

Growth in the historic period resulted from strong economic growth in emerging markets, increased adoption of artificial intelligence (AI) for cost efficient drug discovery and rising implementation of AI in radiology. Factors that negatively affected growth in the historic period was high rate of AI project failures and low healthcare access.

Going forward, adoption of cloud-based applications and services by pharma companies, increasing healthcare expenditure and growing government support rising to AI development will drive the growth. Factor that could hinder the growth of the AI in pharma market in the future include lack of skilled professionals.

AI In Pharma Market Drivers

The key drivers of the AI in pharma market include:

Rising Adoption Of Cloud-Based Applications And Services By Pharma Companies

The rising adoption of cloud-based applications and services by pharmaceutical companies is expected to propel the growth of the AI in pharma market going forward. Cloud-based drug discovery platforms are a cutting-edge method of conducting research and development in the pharmaceutical industry. They leverage data analytics and cloud computing technologies to enhance drug discovery procedures, offering a wide range of tools and functionalities necessary for different facets of drug research and discovery. These platforms improve the efficiency, economy and collaboration of the processes. Pharmaceutical companies are significant market participants and end-users of these platforms, which help these companies handle large amounts of clinical, chemical and biological data by providing secure data storage options.  In March 2023, Nvidia Corporation, a US-based technology company, launched BioNeMo Cloud, to streamline life sciences research, drug discovery and protein engineering. The software provides researchers with access to pre-trained AI models, allowing for customization with proprietary data. Offered as a cloud service, BioNeMo Cloud enables accelerated drug discovery workflows, with US-based biotech company Amgen and several startups already utilizing the platform.  Therefore, the increasing adoption of cloud-based applications and services by pharmaceutical companies will drive the AI in pharma market growth during the forecast period.

AI In Pharma Market Restraints

The key restraints on the AI in pharma market include:

Lack Of Skilled Professionals

The lack of skilled professionals is expected to restrain the growth of the AI in pharma market during the forecast period. The implementation of AI technologies requires specialized skills in data science, machine learning and AI algorithms. The lack of AI professionals could result in longer delays in getting new drugs to market and higher costs for pharma companies developing them.  According to the Global AI Adoption Index 2022 by IBM, a US-based technology company, the barrier to AI adoption for businesses is limited AI skills, expertise or knowledge, with 34% of companies reporting this as a hindrance. Therefore, the lack of skilled professionals may hamper the growth of the AI in pharma market.

AI In Pharma Market Trends

Major trends shaping the AI in pharma market include:

Introduction Of Generative AI In Pharma To Improve Medical Consultations

Companies in the market are increasingly focusing on using generative AI in pharma to improve medical consultations. Generative AI, a subfield of artificial intelligence that focuses on creating new data instances that resemble existing data, has been introduced into the pharmaceutical industry with the potential to revolutionize drug discovery and development and medical records management.  For example, in October 2023, Ubie, a Japan-based medical AI startup, introduced a new Generative AI feature for doctors that streamlines medical record documentation and summarizes patient findings. This feature, known as the 'Medical Interview Summary Function,' uses a Large Language Model (LLM) to generate AI-based summaries from patient visits, specifically summarizing the 20-30 questions related to symptoms and lifestyle habits that patients answer on the 'Ubie Medical Navi' product. The LLM presents this summary on the doctor's PC screen, allowing doctors to quickly understand the patient's symptoms and concerns, thereby improving the quality of medical consultations

Use Of AI In Molecular Target Identification

Major companies operating in the AI in pharma market are increasing their focus on introducing AI in molecular target identification to gain a competitive edge in the market. AI tools are being widely used for molecular target identification and selection in the pharmaceutical industry. Target identification and selection involve discovering a possible molecular target with a specific biological action that is anticipated to have a defined therapeutic activity.  In March 2023, Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-powered pharmaceutical company, integrated an advanced AI chat functionality called 'ChatPandaGPT' into its PandaOmics platform. PandaOmics is an AI-driven target discovery platform that applies deep learning models to identify therapeutic targets associated with a given disease through a combination of omics data analysis and contextual information from publications, clinical trials and grant applications.  

Opportunities And Recommendations In The AI In Pharma Market

Opportunities – The top opportunities in the AI in pharma market segmented by technology will arise in the deep learning segment, which will gain $1,646.13 million of global annual sales by 2027. The top opportunities in the AI in pharma market segmented by drug type will arise in the small molecules segment, which will gain $2,806.31 million of global annual sales by 2027. The top opportunities in the AI in pharma market segmented by application will arise in the drug discovery segment, which will gain $3,708.16 million of global annual sales by 2027. The AI in pharma market size will gain the most in the USA at $1,230.85 million.  

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the AI in pharma companies to focus on introduction of generative AI in pharma,  focus on use of AI in molecular target identification, focus on integration of AI in drug screening process, focus on growing investments to develop new product solutions, focus on fast-growing technologies, expand in emerging markets, continue to focus on developed markets, focus on strategic partnerships and collaborations, focus on competitive pricing, participate in trade shows and events, continue to focus on B2B promotions and continue to target fast-growing applications.

AI in pharma Market Segmentation

The AI In Pharma market is segmented by technology, by drug type and by application.

By Type –
The AI in pharma market is segmented by technology into:
    • a) Context-Aware Processing
    • b) Natural Language Processing
    • c) Querying Method
    • d) Deep Learning
The deep learning market was the largest segment of the AI in pharma market segmented by technology, accounting for 34.3% or $507.30 million of the total in 2022. Going forward, the context-aware processing segment is expected to be the fastest growing segment in the AI in pharma market segmented by technology, at a CAGR of 33.72% during 2022-2027.

By Drug Type –
The AI in pharma market is segmented by drug type into:
    • a) Small Molecule
    • b) Large Molecules
The small molecules market was the largest segment of the AI in pharma market segmented by drug type, accounting for 63.2% or $934.38 million of the total in 2022. Going forward, the large molecules segment is expected to be the fastest growing segment in the AI in pharma market segmented by drug type, at a CAGR of 36.2% during 2022-2027.

By Application Type –
The AI in pharma market is segmented by application type into:
    • a) Diagnosis
    • b) Clinical Trial Research
    • c) Drug Discovery
    • d) Research And Development
    • e) Epidemic Prediction
The drug discovery market was the largest segment of the financial advisory market segmented by application, accounting for 79.7% or $1,177.50 million of the total in 2022. Going forward, the clinical trial research segment is expected to be the fastest growing segment in the financial advisory market segmented by application, at a CAGR of 38.1% during 2022-2027.

By Geography - The AI in pharma market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the AI in pharma market, accounting for 41.7% or $615.92 million of the total in 2022. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the AI in pharma market will be South America and Asia Pacific where growth will be at CAGRs of 42.3% and 40.4% respectively. These will be followed by Eastern Europe and Africa where the markets are expected to grow at CAGRs of 37.7% and 37.3% respectively.

AI In Pharma Market Competitive Landscape

Major Competitors are:

  • Concerto HealthAI
  • Alphabet Inc.
  • OWKIN
  • Nvidia Corporation
  • PathAI

    • Other Competitors Include:

  • Insilico Medicine
  • Exscientia
  • Microsoft Corporation
  • XtalPi
  • Intel
  • Shanghai Pharmaceuticals
  • Standigm
  • Takeda Pharmaceutical Company Ltd
  • Otsuka Pharmaceutical Co. Ltd
  • China National Pharmaceutical Group Co., Ltd. (Sinopharm)
  • Jiangsu Hengrui Medicine Co., Ltd
  • Cipla Limited
  • Aurobindo Pharma Limited
  • Dr. Reddy’s Laboratories Ltd
  • Sun Pharma
  • Roche India
  • Alliance Pharm Pte Ltd
  • GSK Australia
  • DeepMind
  • GlaxoSmithKline
  • Sanofi
  • Bayer
  • Renalytix AI
  • Merck
  • AstraZeneca
  • Exscientia
  • Iktos
  • BenevolentAI
  • Novartis
  • Gero
  • Ardigen
  • Insilico Medicine
  • Botkin
  • Webiomed
  • Care Mentor AI
  • Diagnocat
  • IBM Corporation
  • Atomwise, Inc
  • Cloud Pharmaceutical
  • Bioage
  • NuMedii
  • Envisagenics
  • Aria Pharmaceuticals
  • XtalPi
  • Verge Genomics
  • Berg LLC
  • Deep Genomics
  • Cyclica
  • IQVIA
  • Roche
  • Novartis
  • Pfizer
  • PRA Healthscience
  • Gesto
  • Intensicare
  • Epitrack
  • GE Healthcare
  • Welltok Inc
  • Oncora Medical
  • Recursion Pharmaceuticals Inc
  • Nucleai
  • Pepticom
  • IBM Watson
  • AstraZeneca
  • Rology
  • hearX Group
  • DilenyTech
  • iNNOHEALTH Technology Solutions

      • Table Of Contents

      1Executive Summary

      1.1AI In Pharma – Market Attractiveness And Macro economic Landscape

      2Table Of Contents

      3List Of Tables

      4List Of Figures

      5Report Structure

      6Market Characteristics

      6.1General Market Definition

      6.2Summary

      6.3AI In Pharma Market Definition And Segmentations

      6.4Market Segmentation By Technology

      6.4.1Context-Aware Processing

      6.4.2Natural Language Processing

      6.4.3Querying Method

      6.4.4Deep Learning

      6.5Market Segmentation By Drug Type

      6.5.1Small Molecule

      6.5.2Large Molecules

      6.6Market Segmentation By Application

      6.6.1Diagnosis

      6.6.2Clinical Trial Research

      6.6.3Drug Discovery

      6.6.4Research And Development

      6.6.5Epidemic Prediction

      7Major Market Trends

      7.1Introduction Of Generative AI In Pharma To Improve Medical Consultations

      7.2Use Of AI In Molecular Target Identification

      7.3Integration Of AI In Drug Screening Process To Accelerate Drug Development

      7.4Growing Investments To Develop New Product Solutions

      7.5Strategic Partnerships And Collaborations Among Market Players

      8AI In Pharma Market - Macro Economic Scenario

      8.1COVID-19 Impact On The AI In Pharma Market

      8.2Impact Of The War In Ukraine On The AI In Pharma Market

      8.3Impact Of High Inflation On The AI In Pharma Market

      9Global Market Size and Growth

      9.1Market Size

      9.2Historic Market Growth, 2017 – 2022, Value ($ Million)

      9.2.1Market Drivers 2017 – 2022

      9.2.2Market Restraints 2017 – 2022

      9.3Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      9.3.1Market Drivers 2022 – 2027

      9.3.2Market Restraints 2022 – 2027

      10Global AI In Pharma Market Segmentation

      10.1Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      10.2Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      10.3Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      11AI In Pharma Market, Regional and Country Analysis

      11.1Global AI In Pharma Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      11.2Global AI In Pharma Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12Asia-Pacific Market

      12.1Summary

      12.1.1Market Overview

      12.1.2Region Information

      12.1.3Market Information

      12.1.4Background Information

      12.1.5Government Initiatives

      12.1.6Regulations

      12.1.7Regulatory Bodies

      12.1.8Major Associations

      12.1.9Taxes Levied

      12.1.10Corporate Tax Structure

      12.1.11Investments

      12.1.12Major Companies

      12.2Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.3Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.4Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.5Asia-Pacific AI In Pharma Market: Country Analysis

      12.6China Market

      12.7Summary

      12.7.1Market Overview

      12.7.2Country Information

      12.7.3Market Information

      12.7.4Background Information

      12.7.5Government Initiatives

      12.7.6Regulations

      12.7.7Regulatory Bodies

      12.7.8Major Associations

      12.7.9Taxes Levied

      12.7.10Corporate Tax Structure

      12.7.11Investments

      12.7.12Major Companies

      12.8China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.9China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.1China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.11India Market

      12.12India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.13India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.14India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.15Japan Market

      12.16Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.17Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.18Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.19Australia Market

      12.2Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.21Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.22Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.23Indonesia Market

      12.24Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.25Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.26Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.27South Korea Market

      12.28South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.29South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      12.3South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13Western Europe Market

      13.1Summary

      13.1.1Market Overview

      13.1.2Region Information

      13.1.3Market Information

      13.1.4Background Information

      13.1.5Government Initiatives

      13.1.6Regulations

      13.1.7Regulatory Bodies

      13.1.8Major Associations

      13.1.9Taxes Levied

      13.1.10Corporate Tax Structure

      13.1.11Investments

      13.1.12Major Companies

      13.2Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13.3Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13.4Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13.5Western Europe AI In Pharma Market: Country Analysis

      13.6UK Market

      13.7UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13.8UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13.9UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13.1Germany Market

      13.11Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13.12Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13.13Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13.14France Market

      13.15France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13.16France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      13.17France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      14Eastern Europe Market

      14.1Summary

      14.1.1Market Overview

      14.1.2Region Information

      14.1.3Market Information

      14.1.4Background Information

      14.1.5Government Initiatives

      14.1.6Regulations

      14.1.7Regulatory Bodies

      14.1.8Major Associations

      14.1.9Taxes Levied

      14.1.10Corporate Tax Structure

      14.1.11Investments

      14.1.12Major Companies

      14.2Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      14.3Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      14.4Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      14.5Eastern Europe AI In Pharma Market: Country Analysis

      14.6Russia Market

      14.7Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      14.8Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      14.9Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      15North America Market

      15.1Summary

      15.1.1Market Overview

      15.1.2Region Information

      15.1.3Market Information

      15.1.4Background Information

      15.1.5Government Initiatives

      15.1.6Regulations

      15.1.7Regulatory Bodies

      15.1.8Major Associations

      15.1.9Taxes Levied

      15.1.10Corporate Tax Structure

      15.1.11Investments

      15.1.12Major Companies

      15.2North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      15.3North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      15.4North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      15.5North America AI In Pharma Market: Country Analysis

      15.6USA Market

      15.7Summary

      15.7.1Country Information

      15.7.2Market Information

      15.7.3Background Information

      15.7.4Government Initiatives

      15.7.5Regulations

      15.7.6Regulatory Bodies

      15.7.7Major Associations

      15.7.8Taxes Levied

      15.7.9Corporate Tax Structure

      15.7.10Investments

      15.7.11Major Companies

      15.8USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      15.9USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      15.1USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      16South America Market

      16.1Summary

      16.1.1Market Overview

      16.1.2Region Information

      16.1.3Market Information

      16.1.4Background Information

      16.1.5Government Initiatives

      16.1.6Regulations

      16.1.7Regulatory Bodies

      16.1.8Major Associations

      16.1.9Taxes Levied

      16.1.10Corporate Tax Structure

      16.1.11Investments

      16.1.12Major Companies

      16.2South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      16.3South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      16.4South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      16.5South America AI In Pharma Market: Country Analysis

      16.6Brazil Market

      16.7Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      16.8Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      16.9Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      17Middle East Market

      17.1Summary

      17.1.1Market Overview

      17.1.2Region Information

      17.1.3Market Information

      17.1.4Background Information

      17.1.5Government Initiatives

      17.1.6Regulations

      17.1.7Regulatory Bodies

      17.1.8Major Associations

      17.1.9Taxes Levied

      17.1.10Corporate Tax Structure

      17.1.11Investments

      17.1.12Major Companies

      17.2Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      17.3Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      17.4Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      18Africa Market

      18.1Summary

      18.1.1Market Overview

      18.1.2Region Information

      18.1.3Market Information

      18.1.4Background Information

      18.1.5Government Initiatives

      18.1.6Regulations

      18.1.7Regulatory Bodies

      18.1.8Major Associations

      18.1.9Taxes Levied

      18.1.10Corporate Tax Structure

      18.1.11Investments

      18.1.12Major Companies

      18.2Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      18.3Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      18.4Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

      19Competitive Landscape And Company Profiles

      19.1Company Profiles

      19.2Concerto HealthAI

      19.2.1Company Overview

      19.2.2Products And Services

      19.2.3Business Strategy

      19.2.4Financial Overview

      19.3Alphabet Inc.

      19.3.1Company Overview

      19.3.2Products And Services

      19.3.3Business Strategy

      19.3.4Financial Overview

      19.4OWKIN

      19.4.1Company Overview

      19.4.2Products And Services

      19.4.3Business Strategy

      19.4.4Financial Overview

      19.5Nvidia Corporation

      19.5.1Company Overview

      19.5.2Products And Services

      19.5.3Business Strategy

      19.5.4Financial Overview

      19.6PathAI

      19.6.1Company Overview

      19.6.2Products And Services

      19.6.3Business Strategy

      19.6.4Financial Overview

      20Key Mergers And Acquisitions

      20.1BioNTech Acquired InstaDeep

      20.2Recursion Pharmaceuticals Acquired Cyclica And Valence

      20.3Telix Pharmaceuticals Acquired Dedicaid GmbH

      20.4Envision Pharma Group Acquired OKRA.ai

      20.5Bayer AG Acquired Blackford Analysis Ltd

      20.6iBio Acquired Rubryc Therapeutics

      20.7Genentech Acquired Prescient Design

      20.8Nurosene Health Inc Acquired Netramark Incorporated

      20.9X-Chem Acquired Glamorous AI

      21Opportunities And Strategies

      21.1Global AI In Pharma Market In 2027 – Countries Offering Most New Opportunities

      21.2Global AI In Pharma Market In 2027 – Segments Offering Most New Opportunities

      21.3Global AI In Pharma Market In 2027 – Growth Strategies

      21.3.1Market Trend Based Strategies

      21.3.2Competitor Strategies

      22AI In Pharma Market, Conclusions And Recommendations

      22.1Conclusions

      22.2Recommendations

      22.2.1Product

      22.2.2Place

      22.2.3Price

      22.2.4Promotion

      22.2.5People

      23Appendix

      23.1Geographies Covered

      23.2Market Data Sources

      23.3Research Methodology

      23.4Currencies

      23.5The Business Research Company

      23.6Copyright and Disclaimer

    List Of Tables

      Table 1: Global AI In Pharma Market, Historic, 2017 – 2022, $ Million
    • Table 2: Global AI In Pharma Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 3: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 4: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 5: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 6: Global AI In Pharma Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 7: Global AI In Pharma Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 8: Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 9: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 10: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 11: China GDP Per Capita, By Country, 2017-2022, $
    • Table 12: China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 13: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 14: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 15: India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 16: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 17: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 18: Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 19: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 20: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 21: Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 22: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 23: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 24: Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 25: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 26: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 27: South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 28: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 29: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 30: Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 31: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 32: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 33: UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 34: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 35: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 36: Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 37: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 38: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 39: France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 40: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 41: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 42: Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 43: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 44: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 45: Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 46: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 47: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 48: North America GDP Per Capita, By Country, 2017-2022, $
    • Table 49: North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 50: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 51: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 52: USA GDP Per Capita, By Country, 2017-2022, $
    • Table 53: USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 54: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 55: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 56: South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 57: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 58: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 59: Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 60: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 61: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 62: Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 63: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 64: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 65: Africa GDP Per Capita, By Country, 2017-2022, $
    • Table 66: Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 67: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 68: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Table 69: Global AI In Pharma Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Table 70: Concerto HealthAI – Financial Overview, 2018 – 2022, $ Billion
    • Table 71: Alphabet Inc – Financial Overview, 2018 – 2022, $ Billion
    • Table 72: OWKIN – Financial Overview, 2018 – 2022, $ Billion
    • Table 73: NVIDIA Corporation – Financial Overview, 2018 – 2022, $ Billion
    • Table 74: PathAI – Financial Overview, 2018 – 2022, $ Billion
    • Table 75: Global AI In Pharma Market Size Gain ($ Million), 2022 – 2027, By Country
    • Table 76: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Technology, 2022 – 2027
    • Table 77: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Drug Type, 2022 – 2027
    • Table 78: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Application, 2022 – 2027
    • Table 79: AI In Pharma Market Data Sources

    List Of Figures

      Figure 1: Global AI In Pharma Market Segmentation By Technology
    • Figure 2: Global AI In Pharma Market Segmentation By Drug Type
    • Figure 3: Global AI In Pharma Market Segmentation By Application
    • Figure 4: Global AI In Pharma Market, Historic, 2017 – 2022, $ Million
    • Figure 5: Global AI In Pharma Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 6: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 7: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 8: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 9: Global AI In Pharma Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 10: Global AI In Pharma Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 11: Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 12: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 13: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 14: China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 15: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 16: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 17: India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 18: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 19: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 20: Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 21: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 22: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 23: Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 24: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 25: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 26: Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 27: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 28: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 29: South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 30: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 31: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 32: Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 33: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 34: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 35: UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 36: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 37: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 38: Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 39: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 40: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 41: France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 42: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 43: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 44: Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 45: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 46: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 47: Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 48: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 49: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 50: North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 51: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 52: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 53: USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 54: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 55: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 56: South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 57: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 58: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 59: Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 60: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 61: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 62: Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 63: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 64: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 65: Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 66: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 67: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
    • Figure 68: Global AI In Pharma, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Figure 69: Alphabet Inc – Financial Overview, 2018 – 2022, $ Billion
    • Figure 70: NVIDIA Corporation – Financial Overview, 2018 – 2022, $ Billion
    • Figure 71: Geographic Regions Covered
    Global Cybersecurity Services Market Opportunities And Strategies – Forecast To 2030 – Includes Cybersecurity Services Market Demand
    Read More
    Opportunities And Strategies Analysis For The Supply Chain Management Software Market – Includes Supply Chain Management Software Market Overview
    Read More
    Global Internet Of Things (IoT) Market Opportunities And Strategies – Forecast To 2030 – Includes Internet Of Things (IoT) Market Size
    Read More
    Global Ambulatory Surgical Centers IT Services Market 2022 – Market Opportunities And Strategies
    Read More
    The Business Research Company offers the open source intelligence market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the projection mapping market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the soc as a service market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the employment screening services market research report 2022 with industry size, share, segments and market growth
    Read More
    Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024 – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecules, Large Molecules), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics), By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    CRISPR Technology Global Market Report 2024 – By Product Type (Design Tools, Plasmid And Vector, Cas9 And G-RNA, Delivery System Products), By Application (Biomedical, Agriculture, Diagnostics, Other Applications), By End-User (Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Research Organizations (CROs)) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Biophotonics Global Market Report 2024 – By Product Technology (In-Vitro, In-Vivo), By Application (See-Through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors, Other Applications), By End Use (Diagnostics, Therapeutic, Tests, Other End Uses) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Biosimilars Global Market Report 2024 – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones, Others), By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Synthetic Biology Global Market Report 2024 – By Technology (Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering), By Product Type (Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism), By Application (Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics, Other Application) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    3D Cell Culture Technologies Global Market Report 2024 – By Type (Scaffold-based, Scaffold-free, 3D Bioreactors), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine), By End Users (Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    3D Printed Implants Global Market Report 2024 – By Implantation Technology (Laser Beam Melting, Electronic Beam Melting, Droplet Deposition, Laminated Deposition, Two-photon Polymerization), By Application (Dental, Orthopedic, Cranio-maxillofacial), By End Users (Medical And Surgical Centers, Pharmaceutical Companies, Biotechnology Industry, Medical Institution) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    3D Printed Prosthetics Global Market Report 2024 – By Type (Sockets, Limbs, Joints, Covers, Other Types), By Material (Polypropylene, Polyethylene, Acrylics, Polyurethane), By End-User (Hospitals, Rehabilitation Centers, Prosthetic Clinics) – Market Size, Trends, And Global Forecast 2024-2033
    View Report